Awarded contract

LIONNS-D2 Project - Production of T3S API, IMP and FDF

Details

Buyer: Cardiff University
Supplier(s): Ardena Holding NV
Value: EUR 953,600
Duration: 1 year
Topic: Pharmaceutical products
Published: 23 October 2025
Source: uk:find_a_tender

Tender description

Cardiff University's School of Medicine is procuring the manufacture of a novel investigational medicinal product (IMP), Triiodothyronine sulphate (T3S), for use in a Phase 2b clinical trial. The service includes the production of the active pharmaceutical ingredient (API), the IMP, and the finished drug formulation (FDF) in blister packs. This bespoke drug is intended for hypothyroid patients with a specific genetic variation affecting thyroid hormone metabolism. The supplier will manufacture the product to GMP standards, using a validated Route of Synthesis supported by existing preclinical and toxicology data. ## Contract award Title: LIONNS-D2 Project - Production of T3S API, IMP and FDF

Timeline

Completed: Award date22 October 2025
Completed: Award published23 October 2025
Current notice
Next: Contract expiry date31 January 2027in 5 months

About the buyer

Cardiff University is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

33600000 · Pharmaceutical products

Decision makers

Connect with the people behind this procurement.

Job title	Phone number	Work email
Head of Procurement	+44 •••• ••••••	••••••••@cardiff-university.gov
Commercial Director	+44 •••• ••••••	••••••••@cardiff-university.gov
Procurement Manager	+44 •••• ••••••	••••••••@cardiff-university.gov
Category Lead	+44 •••• ••••••	••••••••@cardiff-university.gov
Senior Buyer	+44 •••• ••••••	••••••••@cardiff-university.gov
Contracts Manager	+44 •••• ••••••	••••••••@cardiff-university.gov